摘要
目的探讨拉坦前列素滴眼液对真性小眼球继发闭角型青光眼的治疗效果。方法系列病例研究。选择2009年6月至2010年7月在首都医科大学附属北京同仁医院眼科中心收治的真性小眼球继发闭角型青光眼5例共9只眼，使用了0．005％拉坦前列素滴眼液或激光虹膜周切后联合0．005％拉坦前列素滴眼液，随访观察3—16个月，对其视力及眼压、眼底及视野等进行了监测。结果真性小眼球继发闭角型青光眼5例患者共9只眼在治疗后眼压控制在10—20mmHg之间，视力无下降，视野及眼底杯／盘比无进展。结论使用0．005％拉坦前列素滴眼液治疗真性小眼球继发闭角型青光眼是安全有效地方法，避免了小梁切除术后可能出现的眼部并发症。
Objective To study the effect of latanoprost on the treatment of nanophthalmos combined angle closure glaucoma. Methods Clinical case series. From June 2009 to July 2010, in Beijing Tongren Eye Center and Beijing Tongren Hospital, five patients （9 eyes） diagnosed as nanophtalmos combined with angle closure glaucoma were treated with latanoprost eye drops and followed up 3 to 16 months for clinical evaluation. The clinical outcomes included visual acuity, lOP, fundus examination and visual field examination. Results in 9 eyes, the lOP was controlled under normal level. The visual acuity, fimdus examination and visual field examination did not vary from the baseline. Conclusions Latanoprost eye drops is effective and safe in the treatment of nanophthalmos combined with angle closure glaucoma.
出处
《中国实用眼科杂志》
CSCD
北大核心
2011年第8期772-774,共3页
Chinese Journal of Practical Ophthalmology
